Interim Results of A Randomized Phase II Trial of Azacitidine (AZA) +/− Epo In Lower Risk Myelodysplastic Syndrome (MDS) Resistant to An Erythropoietic Stimulating Agent (ESA) Alone
Boehrer, Simone, Beyne-Rauzy, Odile, Prebet, Thomas, Park, Sophie, Guerci, Agnès, Stamatoulas, Aspasia, Chaury, MP, Jernival, Tony, Sanhes, Laurence, Tertian, Gerard, Cheze, Stephane, Lim, Eng-Mong, Choufi, Bachra, Caillot, Denis, Wattel, E., Delaunay, Jacques, Legros, Laurence, Chermat, Fatiha, Isnard, Françoise, Cambier, N., Slama, Borhane, Roy, Lydia, Damaj, Gandhi, Raffoux, Emmanuel, Dreyfus, Francois, Récher, Christian, Vey, Norbert, Chevret, Sylvie, Fenaux, Pierre, Gardin, Claude
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
High Response Rate and Improved Exercise Capacity and Quality of Life with a New Regimen of Darbepoetin Alfa (DAR) +/−G-CSF in Lower-Risk MDS : a Phase II Study
Kelaidi, Charikleia, Beyne-Rauzy, Odile, Braun, Thorsten, Cougoul, Pierre, Ades, Lionel, Pillard, Fabien, Lamberto, Christine, Jernival, Tony, Mortera, Edith, Guerci, Agnes, Choufi, B., Stamatoullas, Aspasia, Slama, Borhane, De Renzis, Benoît, Ame, S., Ghandi, Damaj, Boyer, Françoise, Chaury, Marie-Pierre, Legros, Laurence, Cheze, Stéphane, Testu, Anna, Gyan, Emmanuel, Bene, Marie C, Rose, Christian, Dreyfus, Francois, Fenaux, Pierre
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
A Phase II Study of Post–Remission Therapy with Azacitidine (AZA) in Patients with AML Post-MDS and High-Risk MDS: A GFM Group Study
Gardin, Claude, Prébet, Thomas, Bouabdallah, Krimo, Caillot, Denis, Guerci, Agnès, Raffoux, Emmanuel, Marolleau, Jean Pierre, Pautas, Cecile, Banos, Anne, Himberlin, Chantal, Taksin, Anne-Laure, Pigneux, Arnaud, Thomas, Xavier, Jernival, Tony, Vey, Norbert, Dreyfus, Francois, Chevret, Sylvie, Dombret, Herve, Fenaux, Pierre
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article